What do they mean?
Increased levels of bone markers indicate an increased rate of resorption and/or formation of bone but they do not indicate the cause. When they are used to monitor therapy, decreasing levels of bone resorption markers indicate a response to therapy.
FAQs
1. What are the FDA-approved medications for treating osteoporosis? Hormone replacement therapy (HRT), alendronate, calcitonin, raloxifene, and risedronate.
2. How prevalent is osteoporosis? Ten million people in the United States have osteoporosis, and 34 million are at risk of developing the condition. Of those that have osteoporosis, 80% are women.
Related Sites Elsewhere on the Web
NIH Osteoporosis and Related Bone Diseases Resource Center
National Osteoporosis Foundation
The Paget Foundation
